SMYD3 is a member of the SET and MYND Domain (SMYD) lysine methyltransferase family, which includes multi-domain SET methyltransferases implicated in human cancerogenesis, cancer progression, and invasion [2]. This evidence concerns the gene SMYD3 and cancer.